{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:01:41Z","timestamp":1791414101299,"version":"4.3.3"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Cepheid and Achaogen, Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ijantimicag.2011.05.016","type":"journal-article","created":{"date-parts":[[2011,8,6]],"date-time":"2011-08-06T01:26:28Z","timestamp":1312593988000},"page":"352-354","source":"Crossref","is-referenced-by-count":28,"title":["Activity of ACHN-490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals"],"prefix":"10.1016","volume":"38","author":[{"given":"Fred C.","family":"Tenover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Tickler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana S.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Persing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George H.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2011.05.016_bib0005","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1128\/JCM.00521-08","article-title":"Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from global clinical trials","volume":"46","author":"Goering","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.05.016_bib0010","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections in the United States","volume":"298","author":"Klevens","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2011.05.016_bib0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1128\/JCM.44.1.108-118.2006","article-title":"Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States","volume":"44","author":"Tenover","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.05.016_bib0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/107662903322762833","article-title":"In vitro activities of daptomycin, linezolid, and quinupristin\u2013dalfopristin against a challenge panel of staphylococci and enterococci, including vancomycin-intermediate Staphylococcus aureus and vancomycin-resistant Enterococcus faecium","volume":"9","author":"Jevitt","year":"2003","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2011.05.016_bib0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2011.05.016_bib0030","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1086\/533494","article-title":"Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001\u20132004","volume":"197","author":"Gorwitz","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.05.016_bib0035","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1128\/JCM.00480-08","article-title":"Characterization of Staphylococcus aureus isolates from nasal cultures collected from individuals in the United States in 2001 to 2004","volume":"46","author":"Tenover","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.05.016_bib0040","unstructured":"Clinical and Laboratory Standards Institute. Surveillance for methicillin-resistant Staphylococcus aureus: principles, practices, and challenges; a report. Document X-07R. Wayne, PA: CLSI; 2010."},{"key":"10.1016\/j.ijantimicag.2011.05.016_bib0045","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jamcollsurg.2008.12.025","article-title":"Active surveillance screening of MRSA and eradication of the carrier state decreases surgical-site infections caused by MRSA","volume":"208","author":"Pofahl","year":"2009","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ijantimicag.2011.05.016_bib0050","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1128\/AAC.00572-10","article-title":"Synthesis and spectrum of the neoglycoside ACHN-490","volume":"54","author":"Aggen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.016_bib0055","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1128\/AAC.00556-09","article-title":"ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates","volume":"53","author":"Endimiani","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.016_bib0060","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Document M100-S21. Wayne, PA: CLSI; 2011."},{"key":"10.1016\/j.ijantimicag.2011.05.016_bib0065","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th ed. Document M7-A8. Wayne, PA: CLSI; 2009."},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2011.05.016_bib0070","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1093\/clinids\/24.Supplement_1.S46","article-title":"The most frequent aminoglycoside resistance mechanisms\u2014changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups","volume":"24","author":"Miller","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.05.016_bib0075","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1128\/AAC.01350-09","article-title":"Antistaphylococcal activity of ACHN-490 tested alone and in combination with other agents by time\u2013kill assay","volume":"54","author":"Lin","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.016_bib0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/mdr.2009.0869","article-title":"Phenotypic and genotypic evaluation of aminoglycoside resistance in clinical isolates of staphylococci in Tehran, Iran","volume":"15","author":"Emaneini","year":"2009","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2011.05.016_bib0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/dkn430","article-title":"Spread of invasive Spanish Staphylococcus aureus spa-type t067 associated with a high prevalence of the aminoglycoside-modifying enzyme gene ant(4\u2032)-Ia and the efflux pump genes msrA\/msrB","volume":"63","author":"P\u00e9rez-V\u00e1zquez","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.016_bib0090","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1128\/AAC.34.11.2106","article-title":"Molecular analysis of a gentamicin resistance transposonlike element on plasmids isolated from North American Staphylococcus aureus strains","volume":"34","author":"Byrne","year":"1990","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911002627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911002627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T02:37:56Z","timestamp":1592793476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857911002627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0924857911002627"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.05.016","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}